Opportunities and challenges in developing orally administered cannabis edibles

Abel, 2013 Parker, 2017, A review of the scientific evidence on the effects of cannabinoids on brain and behavioral functioning. Gertsch, 2010, Phytocannabinoids beyond the cannabis plant – do they exist?, Bri J Pharmacol, 160, 523, 10.1111/j.1476-5381.2010.00745.x Stolker, 2004, Determination of cannabinoids in cannabis products using liquid chromatography-ion trap mass spectrometry, J Chromatogr A, 1058, 143, 10.1016/S0021-9673(04)01447-5 McPartland, 2001, Cannabis and cannabis extracts: greater than the sum of their parts?, J Cannabis Ther, 1, 103, 10.1300/J175v01n03_08 Volak, 2008, Curcuminoids inhibit multiple human cytochromes p450 (cyp), udp-glucuronosyltransferase (ugt), and sulfotransferase (sult) enzymes, while piperine is a relatively selective cyp3a4 inhibitor, Drug Metab Dispos, 10.1124/dmd.108.020552 Huestis, 2014, Cannabinoid pharmacokinetics and disposition in alternative matrices, 296 Russell, 2018, Routes of administration for cannabis use – basic prevalence and related health outcomes: a scoping review and synthesis, Int J Drug Policy, 52, 87, 10.1016/j.drugpo.2017.11.008 Savage, 2016, Cannabis in pain treatment: clinical and research considerations, J Pain, 17, 654, 10.1016/j.jpain.2016.02.007 Meehan-Atrash, 2017, Toxicant formation in dabbing: the terpene story, ACS Omega, 2, 6112, 10.1021/acsomega.7b01130 Sporkert, 2001, Pharmacokinetic investigations and delta-9-tetrahydrocannabinol and its metabolites after single administration of 10 mg marinol in attendance of a psychiatric study, The Annual Meeting of The International Association of Forensic Toxicologists Rein, 2013, Bioavailability of bioactive food compounds: a challenging journey to bioefficacy, Br J Clin Pharmacol, 75, 588, 10.1111/j.1365-2125.2012.04425.x Wall, 1983, Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women, Clin Pharmacol Ther, 34, 352, 10.1038/clpt.1983.179 Zgair, 2016, Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines, Am J Transl Res, 8, 3448 Huestis, 2005, Pharmacokinetics and metabolism of the plant cannabinoids, δ 9-tetrahydrocannibinol, cannabidiol and cannabinol, Handb Exp Pharmacol, 168, 657, 10.1007/3-540-26573-2_23 Devinsky, 2001, Epidiolex (cannabidiol) in treatment resistant epilepsy Gottlieb, 1993 Verhoeckx, 2006, Unheated cannabis sativa extracts and its major compound thc-acid have potential immuno-modulating properties not mediated by cb1 and cb2 receptor coupled pathways, Int Immunopharmacol, 6, 656, 10.1016/j.intimp.2005.10.002 Rock, 2013, Tetrahydrocannabinolic acid reduces nausea‐induced conditioned gaping in rats and vomiting in suncus murinus, Br J Pharmacol, 170, 641, 10.1111/bph.12316 Parker, 2011, Regulation of nausea and vomiting by cannabinoids, Br J Pharmacol, 163, 1411, 10.1111/j.1476-5381.2010.01176.x Dussy, 2005, Isolation of δ9-thca-a from hemp and analytical aspects concerning the determination of δ9-thc in cannabis products, Forensic Sci Int, 149, 3, 10.1016/j.forsciint.2004.05.015 De Backer, 2009, Innovative development and validation of an hplc/dad method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material, J Chromatogr B, 877, 4115, 10.1016/j.jchromb.2009.11.004 Hewavitharana, 2005, Quantitative gc-ms analysis of δ9-tetrahydrocannabinol in fiber hemp varieties, J Anal Toxicol, 29, 258, 10.1093/jat/29.4.258 Veress, 1990, Determination of cannabinoid acids by high-performance liquid chromatography of their neutral derivatives formed by thermal decarboxylation: I. Study of the decarboxylation process in open reactors, J Chromatogr A, 520, 339, 10.1016/0021-9673(90)85118-F Wang, 2016, Decarboxylation study of acidic cannabinoids: a novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry, Cannabis Cannabinoid Res, 1, 262, 10.1089/can.2016.0020 Garrett, 1974, Physicochemical properties, solubility, and protein binding of tetrahydrocannabinol, J Pharm Sci, 63, 1056, 10.1002/jps.2600630705 Tetko, 2005, Virtual computational chemistry laboratory–design and description, J Comput Aided Mol Des, 19, 453, 10.1007/s10822-005-8694-y Romano, 2013, Cannabis oil: chemical evaluation of an upcoming cannabis-based medicine, Cannabinoids, 1, 1 Ruiz Ruiz, 2017, Encapsulation of vegetable oils as source of omega-3 fatty acids for enriched functional foods, Crit Rev Food Sci Nutr, 57, 1423, 10.1080/10408398.2014.1002906 Sun-Waterhouse, 2012, Storage stability of phenolic-fortified avocado oil encapsulated using different polymer formulations and co-extrusion technology, Food Bioprocess Technol, 5, 3090, 10.1007/s11947-011-0591-x Ezhilarasi, 2013, Nanoencapsulation techniques for food bioactive components: a review, Food Bioprocess Technol, 6, 628, 10.1007/s11947-012-0944-0 Floury, 2000, Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions, Innov Food Sci Emerg Technol, 1, 127, 10.1016/S1466-8564(00)00012-6 Teo, 2016, Interfacial structures of whey protein isolate (wpi) and lactoferrin on hydrophobic surfaces in a model system monitored by quartz crystal microbalance with dissipation (qcm-d) and their formation on nanoemulsions, Food Hydrocoll, 56, 150, 10.1016/j.foodhyd.2015.12.002 Charoen, 2011, Influence of biopolymer emulsifier type on formation and stability of rice bran oil-in-water emulsions: whey protein, gum arabic, and modified starch, J Food Sci, 76, E165, 10.1111/j.1750-3841.2010.01959.x Ozturk, 2014, Formation and stabilization of nanoemulsion-based vitamin e delivery systems using natural surfactants: Quillaja saponin and lecithin, J Food Eng, 142, 57, 10.1016/j.jfoodeng.2014.06.015 Ozturk, 2016, Progress in natural emulsifiers for utilization in food emulsions, Curr Opin Food Sci, 7, 1, 10.1016/j.cofs.2015.07.008 Shah, 2010, Nanoemulsion: a pharmaceutical review, Syst Rev Pharm, 1, 10.4103/0975-8453.59509 Mahdi Jafari, 2006, Nano-emulsion production by sonication and microfluidization—a comparison, Int J Food Properties, 9, 475, 10.1080/10942910600596464 Bai, 2016, Fabrication of oil-in-water nanoemulsions by dual-channel microfluidization using natural emulsifiers: saponins, phospholipids, proteins, and polysaccharides, Food Hydrocoll, 61, 703, 10.1016/j.foodhyd.2016.06.035 Leong, 2009, Minimising oil droplet size using ultrasonic emulsification, Ultrason Sonochem, 16, 721, 10.1016/j.ultsonch.2009.02.008 Kentish, 2008, The use of ultrasonics for nanoemulsion preparation, Innov Food Sci Emerg Technol, 9, 170, 10.1016/j.ifset.2007.07.005 Abbas, 2013, An overview of ultrasound-assisted food-grade nanoemulsions, Food Eng Rev, 5, 139, 10.1007/s12393-013-9066-3 Salvia-Trujillo, 2013, Physicochemical characterization of lemongrass essential oil–alginate nanoemulsions: effect of ultrasound processing parameters, Food Bioprocess Technol, 6, 2439, 10.1007/s11947-012-0881-y Ghosh, 2013, Ultrasonic emulsification of food-grade nanoemulsion formulation and evaluation of its bactericidal activity, Ultrason Sonochem, 20, 338, 10.1016/j.ultsonch.2012.08.010 Cherniakov, 2017, The effect of pro nanolipospheres (pnl) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) in a rat model, Eur J Pharm Sci, 109, 21, 10.1016/j.ejps.2017.07.003 Elgart, 2013, Improved oral bioavailability of bcs class 2 compounds by self nano-emulsifying drug delivery systems (snedds): the underlying mechanisms for amiodarone and talinolol, Pharm Res, 30, 3029, 10.1007/s11095-013-1063-y Lambert, 2004, Piperine enhances the bioavailability of the tea polyphenol (−)-epigallocatechin-3-gallate in mice, J Nutr, 134, 1948, 10.1093/jn/134.8.1948 Agurell, 1986, Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man, Pharmacol Rev, 38, 21 Huestis, 1992, Blood cannabinoids. I. Absorption of thc and formation of 11-oh-thc and thccooh during and after smoking marijuana, J Anal Toxicol, 16, 276, 10.1093/jat/16.5.276 Munjal, 2006, Polymeric systems for amorphous δ9-tetrahydrocannabinol produced by a hot-melt method. Part ii: Effect of oxidation mechanisms and chemical interactions on stability, J Pharm Sci, 95, 2473, 10.1002/jps.20711 Porter, 2007, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs, Nat Rev Drug Discov, 6, 231, 10.1038/nrd2197 Souto, 2006, Polymorphic behaviour of compritol® 888 ato as bulk lipid and as sln and nlc, J Microencapsul, 23, 417, 10.1080/02652040600612439 Punyamurthula, 2015, Controlled release tablet formulation containing natural δ9-tetrahydrocannabinol, Drug Dev Ind Pharm, 42, 1158, 10.3109/03639045.2015.1118490 Hamdani, 2003, Physical and thermal characterisation of precirol® and compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets, Int J Pharm, 260, 47, 10.1016/S0378-5173(03)00229-1 Roberts, 2012, Development and evaluation of sustained-release compritol® 888 ato matrix mini-tablets, Drug Dev Ind Pharm, 38, 1068, 10.3109/03639045.2011.638302 Patere, 2013, Compritol® 888 ato a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and ivivc study, Curr Drug Deliv, 10, 548, 10.2174/1567201811310050006 Jannin, 2006, Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing precirol® ato 5, Int J Pharm, 309, 6, 10.1016/j.ijpharm.2005.10.042 Lopes, 2012, Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis, Eur J Pharm Sci, 45, 442, 10.1016/j.ejps.2011.09.017 Durán-Lobato, 2015, Comparative study of chitosan- and peg-coated lipid and plga nanoparticles as oral delivery systems for cannabinoids, J Nanopart Res, 17, 61, 10.1007/s11051-015-2875-y Zanger, 2013, Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacol Ther, 138, 103, 10.1016/j.pharmthera.2012.12.007